Janux Therapeutics (JANX) Interest Coverage Ratio (2020 - 2026)

Janux Therapeutics (JANX) has 7 years of Interest Coverage Ratio data on file, last reported at 1.2 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 351.23% year-over-year to 1.2 in Q1 2026; TTM through Mar 2026 was 5.51, a 536.12% decrease from a year earlier, with the FY2025 full-year figure at 5.33, down 1848.8% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 1.2, down from 0.33 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for JANX reached as high as 0.05 in Q2 2024 and fell as low as 53.1 in Q4 2022.
• Historically, Interest Coverage Ratio has averaged 4.22 across 5 years, with a median of 0.46 in 2022.
• Across the five-year window, Interest Coverage Ratio jumped 91.5% in 2024 and plunged 849.0% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 53.1 in 2022, then surged by 98.02% to 1.05 in 2023, then surged by 89.1% to 0.11 in 2024, then slumped by 188.57% to 0.33 in 2025, then tumbled by 263.86% to 1.2 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 1.2 in Q1 2026, 0.33 in Q3 2025, and 0.46 in Q2 2025.